NorthWest Biotherapeutics Inc (NWBO)

[sbnyc]

The Lancet - Editorial: Our Commitment to Help Accelerate Progress Against Cancer

Published:February 26, 2022

“Impressive advances in imaging, genomics, radiology, and personalised treatments have greatly improved cancer treatment, contributing to remarkable improvements in cancer survival, particularly in high-income countries. However, in low-income countries, inadequate access to essential core technologies in surgery, radiotherapy, pathology, and chemotherapy is a huge barrier to effective cancer care. To take just one example, between 2015 and 2019, the average global 5-year childhood cancer survival ranged from 11·6% in Africa to 83·0% in North America. An ethos in cancer that focuses on health systems and better care, and not just on innovation, is essential to ensure the best outcomes for all.”

DOI:https://doi.org/10.1016/S0140-6736(22)00371-3

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00371-3/fulltext